AreƱo, Edna L.

HRN: 22-48-70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/20/2023
03/26/2023
IV
600mg
Q8
SSI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: